Fevertree Drinks (FEVR) AI Stock Analysis

• Market Cap: $1.08B
• Dividend Yield: 1.85%
• Average Volume (3M): 458.48K
• Price to Earnings (P/E): 41.6
• Beta (1Y): 1.33
• Revenue Growth: -6.03%
• EPS Growth: 13.11%
• Country: UK
• Employees: 380
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Beverages - Non-Alcoholic
• EPS (TTM): 0.10
• Shares Outstanding: 117,864,610
• 10 Day Avg. Volume: 618,168
• 30 Day Avg. Volume: 458,476
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.95
• Enterprise Value/Revenue: 2.79
• Enterprise Value/Gross Profit: 7.98
• Enterprise Value/Ebitda: 22.50
• 1Y Price Target: $846.48
• Price Target Upside: -7.59% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 7

• Rating: 70 Outperform
• Price Target: 960.00p ▲(4.80% Upside)

Fevertree Drinks' overall stock score is driven by its strong financial performance, characterized by consistent revenue growth and robust cash flow management. However, the high P/E ratio suggests potential overvaluation, and mixed technical indicators point to possible volatility. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Negative Factors

Fevertree Drinks Business Overview & Revenue Model

Company Description

Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, Clementine tonic water, ginger beer, ginger ale, and cola distillers. It sells its products under Fever-Tree brand name to pubs, bars, and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Fevertree Drinks generates revenue primarily through the sale of its premium mixers to both retail and wholesale customers. The company benefits from a growing trend of consumers seeking high-quality mixers to enhance their drinking experience, particularly in the cocktail and spirits sector. Key revenue streams include direct sales to supermarkets, specialty retailers, and distribution agreements with bars and restaurants. Additionally, Fevertree has established significant partnerships with major beverage brands and distributors, which help expand its market reach and enhance brand visibility. The company's focus on innovation and product development, along with its marketing strategies, contributes to its strong financial performance.

Fevertree Drinks Financial Statement Overview

Summary

Fevertree Drinks shows strong financial health with consistent revenue growth, solid margins, and robust cash flow. The balance sheet is healthy with low debt and high equity, supporting stability and growth prospects.

Income Statement

Fevertree Drinks has shown consistent revenue growth over the years, with a notable increase from 2023 to 2024. The gross profit margin and EBIT margin remain solid, indicating effective cost management. However, the net profit margin is relatively moderate due to industry competition. The company's strong EBITDA margin highlights operational efficiency.

Balance Sheet

The company maintains a robust balance sheet with a healthy equity ratio. Fevertree Drinks has low debt levels, resulting in a favorable debt-to-equity ratio. The return on equity is strong, reflecting effective use of shareholders' funds. However, the company's asset base growth is moderate, suggesting a focus on maintaining financial stability.

Cash Flow

Fevertree Drinks demonstrates a strong cash flow position, with significant free cash flow growth from 2023 to 2024. The operating cash flow to net income ratio indicates efficient cash generation relative to profits. The free cash flow to net income ratio is also robust, underscoring the company's ability to generate cash beyond its net earnings.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	368.50M	364.40M	344.30M	311.10M	252.10M
Gross Profit	138.40M	109.00M	118.80M	130.90M	116.30M
EBITDA	45.70M	30.80M	37.20M	60.60M	55.60M
Net Income	24.40M	15.40M	24.90M	44.60M	41.70M
Balance Sheet
Total Assets	321.90M	313.70M	311.60M	336.10M	298.40M
Cash, Cash Equivalents and Short-Term Investments	96.00M	59.90M	95.30M	166.20M	143.10M
Total Debt	12.10M	15.20M	16.90M	2.90M	1.90M
Total Liabilities	75.20M	75.90M	72.40M	54.50M	45.80M
Stockholders Equity	246.70M	237.80M	239.20M	281.60M	252.60M
Cash Flow
Free Cash Flow	56.10M	-13.40M	1.40M	42.20M	35.50M
Operating Cash Flow	70.20M	-3.80M	8.50M	46.80M	38.10M
Investing Cash Flow	-10.80M	-9.60M	-10.00M	-4.30M	-3.80M
Financing Cash Flow	-23.60M	-23.10M	-70.70M	-19.30M	-19.60M

Fevertree Drinks Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 916.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FEVR, the sentiment is Positive. The current price of 916 is above the 20-day moving average (MA) of 832.65, above the 50-day MA of 893.64, and above the 200-day MA of 796.81, indicating a bullish trend. The MACD of 1.77 indicates Negative momentum. The RSI at 58.94 is Neutral, neither overbought nor oversold. The STOCH value of 83.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:FEVR.

Fevertree Drinks Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CCH	75 Outperform	13.06B	17.08	25.60%	2.10%	6.00%	42.42%
BAG	71 Outperform	764.27M	19.02	12.50%	2.45%	5.10%	3.23%
FEVR	70 Outperform	$1.08B	41.64	9.97%	1.85%	-6.03%	13.11%
PFD	69 Neutral	1.61B	12.96	8.66%	1.50%	1.01%	11.12%
NICL	64 Neutral	442.40M	23.60	21.22%	2.65%	3.04%	-6.67%
CCR	54 Neutral	595.23M	53.25	2.43%	5.32%	-1.80%	0.00%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Fevertree Drinks Corporate Events

Fever-Tree Director Increases Stake with Share Purchase

Fever-Tree announced that Kevin Havelock, the Senior Independent Non-Executive Director, purchased 37,000 ordinary shares in the company at an average price of GBP 8.46 per share on 11 September 2025 via the London Stock Exchange. This transaction signifies a vote of confidence in the company’s future prospects by a key member of its leadership, potentially impacting investor sentiment and market perception positively.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £8.50 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fever-Tree Proposes Share Premium Cancellation to Boost Reserves

Fever-Tree has announced a proposed cancellation of its share premium account to create distributable reserves that could support share buybacks, future dividend payments, and other corporate purposes. The proposal is contingent upon shareholder approval and court confirmation, with the final hearing expected on 11 November 2025. The cancellation will not affect the rights or number of ordinary shares. The General Meeting to discuss this will be held on 17 October 2025.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £906.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Reports Strategic Progress and Financial Growth in FY25 Interim Results

Fevertree Drinks PLC has reported its FY25 interim results, highlighting strategic progress and alignment with full-year expectations. The company has entered a significant partnership with Molson Coors, granting them exclusive rights to sell, distribute, and produce Fever-Tree products in the US, which is progressing well. Product diversification beyond tonic water has been successful, contributing to 45% of the group’s revenues. Despite challenges in the UK market, the company’s off-trade performance remains robust. Financially, the group has seen a 2% revenue growth at constant currency, with a notable increase in cash position due to strong cash flow and Molson Coors’ transaction inflows. The company has extended its share buyback program, reflecting confidence in its earnings quality.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £906.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback Program

Fevertree Drinks PLC has repurchased 46,384 of its ordinary shares at an average price of 783.6275 pence per share as part of its ongoing buyback program. This move, authorized by shareholders, is intended to cancel the purchased shares, potentially impacting the company’s stock value and shareholder equity.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £906.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 89,775 ordinary shares as part of its share buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s ongoing strategy to enhance shareholder value and optimize its capital structure.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £906.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Fevertree Drinks PLC Executes Share Buyback to Enhance Shareholder Value

Fevertree Drinks PLC announced the repurchase of 87,898 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This move, executed through Investec Bank, reflects the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its stock performance and market perception.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £906.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.